X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc.

XFOR
X4 Pharmaceuticals, Inc.US flagNASDAQ Capital Market
3.97
USD
-0.07
- -
374.45MMarket Cap

X4 Pharmaceuticals, Inc. (XFOR) Stock Splits

Learn about X4 Pharmaceuticals, Inc.'s most recent 1-for-30 basis stock split on April 28, 2025. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about X4 Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2025-04-28
Split Ratio: 1:30
Price Before Split: $0.18
Price After Split: $0.01

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 30.00 times fewer shares (a 1:30 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of X4 Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-04-281:30Yes$0.18$0.01
2019-03-141:6Yes$2.53$0.42

About X4 Pharmaceuticals, Inc.

Company overview and industry information

X4 Pharmaceuticals, Inc. (XFOR) operates in the Biotechnology industry. The recent 1-for-30 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to X4 Pharmaceuticals, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.